Researchers have identified a genetic test that when used with DNA testing would detect a higher number of genetic mutations in colorectal cancer patients, according to a study in the February 16 ...

Aligning cancer quality metrics across the continuum of community-based and academic medicine using a prioritization tool. This is an ASCO Meeting Abstract from the 2012 Quality Care Symposium. This ...

Today, doctors are increasingly looking at the genetic makeup of each patient’s tumor to guide treatment decisions.

Testing for breast cancer and other diseases caused by BRCA1 and BRCA2 genetic mutations becomes easier now that the U.S. Federal Drug Administration has approved 23andMe's genetic test. The test kit ...

Amanda Nerstad was 39 years old and a busy working mother of two young children when she learned she had metastatic lung cancer in 2016. She was given between two weeks and nine months to live. Her ...

Previously, it was recommended for women who have a family history of breast, ovarian, tubal or peritoneal cancer to be assessed for harmful BRCA1 or BRCA2 mutations. That recommendation was last made ...

Add Yahoo as a preferred source to see more of our stories on Google. A new "proteomic" blood test can accurately screen a newborn's DNA for thousands of rare, inherited diseases by analyzing just a ...